The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Early Identification of Refractory Epilepsy
Open accessAbstract
BACKGROUND: More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures. METHODS: We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year. RESULTS: Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent). CONCLUSIONS: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the remaining 30% have drug-resistant epilepsy requiring consideration of surgical intervention, ketogenic dietary therapy, vagus nerve stimulation, or other neuromodulatory approaches6,7”
In the citing paper
“While approximately 70% of patients can achieve seizure freedom with appropriate antiepileptic drug (AED) therapy”
Citations
Cites
Guidelines for Epidemiologic Studies on Epilepsy
(1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb00433.x · Cited by 1,360
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M., Adam, C., Broglin, D., Arzimanoglou, A. A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,105
Engel, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603073341008 · Cited by 880
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M. L., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 725
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. W. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 614
Self-citationMDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. W. T. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 525
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 462
Self-citation
Research works printed but not linked: 2
- Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:517-24.
- Wolf P. International classification of the epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:773-7.
Cited by
Sorted by citations
Items 301–400 of 1,005
Lattanzi, S., Trinka, E., Striano, P., Rocchi, C., Salvemini, S., Silvestrini, M., & Brigo, F. (2021) · CNS Drugs · doi:10.1007/s40263-021-00807-y · Cited by 126
Initial Management of Epilepsy
French, J. A., & Pedley, T. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801738 · Cited by 126
Approaches to refractory epilepsy
Engel, J. (2014) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.128644 · Cited by 125
Pharmacoresistant epilepsy: From pathogenesis to current and emerging therapies
Pati, S. B. B., & Alexopoulos, A. V. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.09061 · Cited by 125
Embodiment and estrangement: results from a first-in-human “intelligent BCI” trial
Gilbert, F., Cook, M., O’Brien, T., & Illes, J. (2019) · Science and Engineering Ethics · doi:10.1007/s11948-017-0001-5 · Cited by 129
French, J. A., Kanner, A. M., Bautista, J. F., Abou-Khalil, B. W., Browne, T. R., Harden, C. L., Theodore, W. H., Bazil, C. W., Stern, J. M., Schachter, S. C., et al. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.06204.x · Cited by 125
Dossi, E., Blauwblomme, T., Moulard, J., Chever, O., Vasile, F., Guinard, E., Bert, M. L., Couillin, I., Pallud, J., Capelle, L., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar3796 · Cited by 124
West, S., Nevitt, S. J., Cotton, J., Gandhi, S. E., Weston, J., Sudan, A., Ramirez, R., & Newton, R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010541.pub3 · Cited by 127
Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges
Cervenka, M. C., Henry-Barron, B. J., Felton, E. A., Patton, K., & Kossoff, E. H. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.02.038 · Cited by 123
Dixit, A. B., Banerjee, J., Srivastava, A., Tripathi, M., Sarkar, C., Kakkar, A., Jain, M., & Chandra, P. S. (2016) · Genomics · doi:10.1016/j.ygeno.2016.04.001 · Cited by 123
Chronic deep brain stimulation in mesial temporal lobe epilepsy
Boëx, C., Seeck, M., Vulliémoz, S., Rossetti, A. O., Staedler, C., Spinelli, L., Pegna, A. J., Pralong, É., Villemure, J., Foletti, G. B., et al. (2011) · Seizure · doi:10.1016/j.seizure.2011.03.001 · Cited by 128
Levetiracetam: a comprehensive review
Crepeau, A. Z., & Treiman, D. M. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.3 · Cited by 123
MRI-identified pathology in adults with new-onset seizures
Hakami, T. M., McIntosh, A. M., Todaro, M., LUI, E. H., Yerra, R., Tan, K. M., French, C. R., Li, S., Desmond, P. M., Matkovic, Z., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a35193 · Cited by 123
Trinka, E., Marson, A. G., Van Paesschen, W., Kälviäinen, R., Marovac, J., Duncan, B., Buyle, S., Hallström, Y., Hon, P., Muscas, G. C., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300376 · Cited by 121
Lattanzi, S., Trinka, E., Zaccara, G., Striano, P., Russo, E., Giovane, C. D., Silvestrini, M., & Brigo, F. (2022) · Drugs · doi:10.1007/s40265-021-01661-4 · Cited by 122
Should Antiepileptic Drugs Be Withdrawn in Seizure-Free Patients?
Specchio, L. M., & Beghi, E. (2004) · CNS Drugs · doi:10.2165/00023210-200418040-00001 · Cited by 122
Epilepsy surgery, delays and referral patterns—are all your epilepsy patients controlled?
Benbadis, S. R., Heriaud, L., Tatum, W. O., & Vale, F. Ĺ. (2003) · Seizure · doi:10.1016/s1059-1311(02)00320-5 · Cited by 122
Zhang, B., McDaniel, S. S., Rensing, N. R., & Wong, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057445 · Cited by 123
Fiest, K. M., Birbeck, G. L., Jacoby, A., & Jetté, N. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0444-x · Cited by 121
Influences of electromagnetic radiation distribution on chaotic dynamics of a neural network
Lin, H., & Wang, C. (2019) · Applied Mathematics and Computation · doi:10.1016/j.amc.2019.124840 · Cited by 122
Hessen, E., Lossius, M. I., Reinvang, I., & Gjerstad, L. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00805.x · Cited by 121
Randomized dose-controlled study of topiramate as first-line therapy in epilepsy
Arroyo, S., Dodson, W. E., Privitera, M., Glauser, T. A., Naritoku, D. K., Dlugos, D., Wang, S., Schwabe, S., Twyman, R. E., & for the EPMN-106/INT-28 Investigators (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00485.x · Cited by 121
Nugent, A. C., Martinez, A. R., D'Alfonso, A., Zarate, C. A., & Theodore, W. H. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.228 · Cited by 120
Ketogenic diet treatment in adults with refractory epilepsy
Klein, P., Janousek, J., Barber, A., & Weissberger, R. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.09.016 · Cited by 120
Cho, H., Lee, H.-Y., Han, M., Choi, J., Ahn, S. H., Lee, T., Chang, Y., & Park, J. (2016) · Scientific Reports · doi:10.1038/srep31201 · Cited by 126
Touma, L., Dansereau, B., Chan, A. Y., Jetté, N., Kwon, C., Braun, K. P. J., Friedman, D., Jehi, L. E., Rolston, J. D., Vadera, S., et al. (2022) · Epilepsia · doi:10.1111/epi.17243 · Cited by 124
Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy
Kwan, P., & Brodie, M. J. (2003) · Neurology · doi:10.1212/wnl.60.11_suppl_4.s2 · Cited by 120
Self-citationCurrent management and surgical outcomes of medically intractable epilepsy
Ramey, W. L., Martirosyan, N. L., Lieu, C. M., Hasham, H. A., Lemole, G. M., & Weinand, M. E. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.09.035 · Cited by 119
Recent developments on triazole nucleus in anticonvulsant compounds: a review
Song, M., & Deng, X. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1423068 · Cited by 120
Clinical pharmacology and therapeutic use of the new antiepileptic drugs
Perucca, E. (2001) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2001.00055.x · Cited by 119
Refractory Epilepsy: A Clinically Oriented Review
Beleza, P. (2009) · European Neurology · doi:10.1159/000222775 · Cited by 119
Tavakol, S., Royer, J., Lowe, A. J., Bonilha, L., Tracy, J. I., Jackson, G. D., Duncan, J. S., Bernasconi, A., Bernasconi, N., & Bernhardt, B. C. (2019) · Epilepsia · doi:10.1111/epi.14688 · Cited by 118
Enhancing antiepileptic drug adherence: A randomized controlled trial
Brown, I., Sheeran, P., & Reuber, M. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.09.014 · Cited by 118
Intermittent fasting: A “new” historical strategy for controlling seizures?
Hartman, A. L., Rubenstein, J. E., & Kossoff, E. H. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.10.011 · Cited by 117
Wheless, J. W., Dlugos, D., Miller, I., Oh, D. A., Parikh, N., Phillips, S. E., Renfroe, J. B., Roberts, C. M., Saeed, I., Sparagana, S. P., et al. (2019) · CNS Drugs · doi:10.1007/s40263-019-00624-4 · Cited by 127
The methylation hypothesis: Do epigenetic chromatin modifications play a role in epileptogenesis?
Kobow, K., & Blümcke, I. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03145.x · Cited by 118
A survey of neurologists’ views on epilepsy surgery and medically refractory epilepsy
Hakimi, A. S., Spanaki, M. V., Schuh, L. A., Smith, B. J., & Schultz, L. R. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.02.003 · Cited by 117
A modern epilepsy surgery treatment algorithm: Incorporating traditional and emerging technologies
Englot, D. J. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.12.041 · Cited by 116
Sohrabpour, A., Cai, Z.-X., Ye, S., Brinkmann, B., Worrell, G., & He, B. (2020) · Nature Communications · doi:10.1038/s41467-020-15781-0 · Cited by 118
Practical considerations in epilepsy neurostimulation
Simpson, H. D., Schulze‐Bonhage, A., Cascino, G. D., Fisher, R. S., Jobst, B. C., Sperling, M. R., & Lundstrom, B. N. (2022) · Epilepsia · doi:10.1111/epi.17329 · Cited by 121
Kobau, R., & DiIorio, C. K. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00057-x · Cited by 116
Surgical Treatment for Epilepsy
Engel, J. (2008) · JAMA · doi:10.1001/jama.2008.756 · Cited by 116
Steinig, I., von Podewils, F., Möddel, G., Bauer, S., Klein, K. M., Paule, E., Reif, P. S., Willems, L. M., Zöllner, J. P., Kunz, R., et al. (2017) · Epilepsia · doi:10.1111/epi.13768 · Cited by 115
Forecasting cycles of seizure likelihood
Karoly, P. J., Cook, M. J., Maturana, M. I., Nurse, E. S., Payne, D. E., Brinkmann, B. H., Grayden, D. B., Dumanis, S. B., Richardson, M. P., Worrell, G. A., et al. (2020) · Epilepsia · doi:10.1111/epi.16485 · Cited by 110
The Liverpool Adverse Events Profile: Relation to AED Use and Mood
Panelli, R. J., Kilpatrick, C. J., Moore, S. M., Matkovic, Z., D'Souza, W. J., & O'Brien, T. J. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2006.00956.x · Cited by 115
Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries
Cameron, A., Bansal, A., Dua, T., Hill, S. R., Moshé, S. L., Mantel-Teeuwisse, A. K., & Saxena, S. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03446.x · Cited by 115
Evidence-based review on the natural history of the epilepsies
Schmidt, D., & Sillanpää, M. L. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283507e73 · Cited by 114
The Evaluation of Laser Application in Surgery: A Review Article
Khalkhal, E., Rezaei–Tavirani, M., Zali, M. R., & Akbari, Z. (2019) · Journal of lasers in medical sciences · doi:10.15171/jlms.2019.s18 · Cited by 114
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data
Nevitt, S. J., Sudell, M., Cividini, S., Marson, A. G., & Smith, C. T. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011412.pub4 · Cited by 119
Survival Analysis of the Surgical Outcome of Temporal Lobe Epilepsy Due to Hippocampal Sclerosis
Paglioli, E., Palmini, A., Paglioli, E., da Costa, J. C., Portuguez, M. W., Martinez, J. V., Calcagnotto, M. E., Hoefel, J. R., Raupp, S. F., & Barbosa-Coutinho, L. M. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.22204.x · Cited by 114
Seizure freedom with more than one antiepileptic drug
Stephen, L. J., & Brodie, M. J. (2002) · Seizure · doi:10.1053/seiz.2002.0711 · Cited by 114
Self-citationShneker, B. F., & Fountain, N. B. (2003) · Disease-a-Month · doi:10.1016/s0011-5029(03)00065-8 · Cited by 114
Editorial: Epidemiology of epilepsy and seizures
Chen, Z. Z., Brodie, M. J., Ding, D., & Kwan, P. (2023) · Frontiers in Epidemiology · doi:10.3389/fepid.2023.1273163 · Cited by 114
Self-citationAihua, L., Song, L., Liping, L., Xiu-ru, W., Hua, L., & Wang, Y. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.005 · Cited by 115
Hakimova, H., Kim, S., Chu, K., Lee, S. K., Jeong, B., & Jeon, D. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.008 · Cited by 117
Structural brain changes in medically refractory focal epilepsy resemble premature brain aging
Pardoe, H., Cole, J. H., Blackmon, K., Thesen, T., & Kuzniecky, R. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.03.007 · Cited by 114
Baldassano, S. N., Brinkmann, B. H., Ung, H., Blevins, T., Conrad, E. C., Leyde, K. W., Cook, M. J., Khambhati, A. N., Wagenaar, J., Worrell, G. A., et al. (2017) · Brain · doi:10.1093/brain/awx098 · Cited by 113
Alteration of Gut Microbiota in Patients With Epilepsy and the Potential Index as a Biomarker
Gong, X., Liu, X., Chen, C., Lin, J., Li, A., Guo, K., An, D., Zhou, D., & Hong, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.517797 · Cited by 117
Giacobbe, P., Mayberg, H. S., & Lozano, A. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.028 · Cited by 112
Road to refractory epilepsy: The G lasgow story
Brodie, M. J. (2013) · Epilepsia · doi:10.1111/epi.12175 · Cited by 112
Self-citationPerspectives of zebrafish models of epilepsy: What, how and where next?
Stewart, A., Desmond, D. H., Kyzar, E. J., Gaikwad, S., Roth, A., Riehl, R., Collins, C. J., Monnig, L., Green, J. B. A., & Kalueff, A. V. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.020 · Cited by 112
Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
Ben‐Menachem, E., Mameniškienė, R., Quarato, P. P., Klein, P., Gamage, J., Schiemann, J., Johnson, M. E., Whitesides, J., McDonough, B., & Eckhardt, K. (2016) · Neurology · doi:10.1212/wnl.0000000000002864 · Cited by 112
Farrell, J. S., Colangeli, R., Wolff, M. D., Wall, A. K., Phillips, T. J., George, A. G., Federico, P., & Teskey, G. C. (2017) · Epilepsia · doi:10.1111/epi.13827 · Cited by 112
Towards Realizing the Vision of Precision Medicine: AI Based Prediction of Clinical Drug Response
de Jong, J., Cutcutache, I., Page, M., Elmoufti, S., Dilley, C., Fröhlich, H., & Armstrong, M. (2020) · Brain · doi:10.1093/brain/awab108 · Cited by 112
Reflex seizures, traits, and epilepsies: from physiology to pathology
Koepp, M. J., Caciagli, L., Pressler, R., Lehnertz, K., & Beniczky, S. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00219-7 · Cited by 117
The RNS System: brain-responsive neurostimulation for the treatment of epilepsy
Jarosiewicz, B., & Morrell, M. J. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2019.1683445 · Cited by 113
A randomized trial of polyunsaturated fatty acids for refractory epilepsy
Bromfield, E. B., Dworetzky, B. A., Hurwitz, S., Eluri, Z., Lane, L., Replansky, S., & Mostofsky, D. I. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.09.011 · Cited by 115
Rufinamide: a new anti-epileptic medication
Hakimian, S., Cheng-Hakimian, A., Anderson, G. D., & Miller, J. W. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.12.1931 · Cited by 111
The effects of cognitive rehabilitation on memory outcome after temporal lobe epilepsy surgery
Helmstaedter, C., Loer, B., Wohlfahrt, R., Hammen, A., Saar, J., Steinhoff, B. J., Quiske, A., & Schulze‐Bonhage, A. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.11.010 · Cited by 110
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
Rogawski, M. A. (2013) · Epilepsia · doi:10.1111/epi.12182 · Cited by 110
Quality improvement in neurology
Fountain, N. B., Ness, P. C. V., Bennett, A., Absher, J. R., Patel, A. D., Sheth, K. N., Gloss, D. S., Morita, D. A., & Stecker, M. (2015) · Neurology · doi:10.1212/wnl.0000000000001448 · Cited by 110
A Review of Neurostimulation for Epilepsy in Pediatrics
Starnes, K., Miller, K. J., Wong‐Kisiel, L. C., & Lundstrom, B. N. (2019) · Brain Sciences · doi:10.3390/brainsci9100283 · Cited by 110
Seizure forecasting and cyclic control of seizures
Stirling, R. E., Cook, M. J., Grayden, D. B., & Karoly, P. J. (2020) · Epilepsia · doi:10.1111/epi.16541 · Cited by 110
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data
Nevitt, S. J., Sudell, M., Weston, J., Smith, C. T., & Marson, A. G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011412.pub2 · Cited by 110
Epilepsy in Border Collies: Clinical Manifestation, Outcome, and Mode of Inheritance
Hülsmeyer, V., Zimmermann, R., Brauer, C., Sauter‐Louis, C., & Fischer, A. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2009.0438.x · Cited by 110
Gabapentin versus Lamotrigine Monotherapy: A Double‐blind Comparison in Newly Diagnosed Epilepsy
Brodie, M. J., Chadwick, D. W., Anhut, H., Otte, A., Messmer, S., Maton, S., Sauermann, W., Murray, G., Garofalo, E. A., & for the Gabapentin Study Group 945‐212 (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.45401.x · Cited by 110
Self-citationAdverse antiepileptic drug effects in new-onset seizures
Perucca, P., Jacoby, A., Marson, A. G., Baker, G. A., Lane, S., Benn, E. K. T., Thurman, D. J., Hauser, W. A., Gilliam, F. G., & Hesdorffer, D. C. (2011) · Neurology · doi:10.1212/wnl.0b013e318207b073 · Cited by 109
Pilot Study of Trigeminal Nerve Stimulation (TNS) for Epilepsy: A Proof‐of‐Concept Trial
DeGiorgio, C. M., Shewmon, A., Murray, D., & Whitehurst, T. K. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00594.x · Cited by 109
Chapman, S., Horne, R., Chater, A., Hukins, D., & Smithson, W. H. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.016 · Cited by 109
Naydenov, A. V., Horne, E. A., Cheah, C. S., Swinney, K., Hsu, K., Cao, J. K., Marrs, W., Blankman, J. L., Tu, S., Cherry, A. E., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.030 · Cited by 111
Billiau, A., Witters, P., Ceulemans, B., Kasran, A., Wouters, C. H., & Lagae, L. G. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01134.x · Cited by 109
Deep brain stimulation of the anterior nucleus of the thalamus for drug-resistant epilepsy
van der Vlis, T. A. M. B., Schijns, O. E. M. G., Schaper, F. L. W. V. J., Hoogland, G., Kubben, P., Wagner, L., Rouhl, R. P. W., Temel, Y., & Ackermans, L. P. C. M. (2018) · Neurosurgical Review · doi:10.1007/s10143-017-0941-x · Cited by 109
Neuro-Detect: A Machine Learning-Based Fast and Accurate Seizure Detection System in the IoMT
Sayeed, M. A., Mohanty, S. P., Kougianos, E., & Zaveri, H. P. (2019) · IEEE Transactions on Consumer Electronics · doi:10.1109/tce.2019.2917895 · Cited by 109
Peltola, J., Colon, A., Pimentel, J., Coenen, V. A., Gil‐Nagel, A., Gonçalves-Ferreira, A., Lehtimäki, K. A., Ryvlin, P., Taylor, R. S., Ackermans, L. P. C. M., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000206887 · Cited by 113
“Of the 50 million people with epilepsy worldwide, one-third continue to have seizures despite appropriate antiseizure medications (ASMs).(1) Many patients with drug-resistant epilepsy (DRE) cannot undergo resective epilepsy surgery due to poorly localized or multifocal onset(2) or seizure origin within eloquent cortex.”
BackgroundŁuszczki, J. J., Borowicz, K. K., Świąder, M., & Czuczwar, S. J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.32702.x · Cited by 109
New Developments in Antiepileptic Drug Resistance: An Integrative View
Schmidt, D., & Löscher, W. (2009) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2008.01289.x · Cited by 108
Understanding the Delay Before Epilepsy Surgery: Who Develops Intractable Focal Epilepsy and When?
Berg, A. T. (2004) · CNS Spectrums · doi:10.1017/s109285290000849x · Cited by 108
Standardisation framework for the Maudsley staging method for treatment resistance in depression
Fekadu, A., Donocik, J. G., & Cleare, A. J. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1679-x · Cited by 106
Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia
Swanson, M. A., Coughlin, C. R., Scharer, G. H., Szerlong, H. J., Bjoraker, K., Spector, E., Creadon‐Swindell, G., Mahieu, V., Matthijs, G., Hennermann, J. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24485 · Cited by 107
The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism
Fan, H., Lee, H.-S., Chang, K., Lee, Y., Lai, H.-C., Hung, P., Lee, H.-F., & Chi, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081242 · Cited by 110
Temporal lobe epilepsy: analysis of failures and the role of reoperation
Salanova, V., Markand, O. N., & Worth, R. M. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00371.x · Cited by 107
A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy
Lambrechts, D. A. J. E., de Kinderen, R. J. A., Vles, J. S. H., de Louw, A. J. A., Aldenkamp, A. P., & Majoie, M. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12737 · Cited by 107
The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence
Schön, M., Mousa, A., Berk, M., Chia, W. L., Ukropec, J., Majid, A., Ukropcová, B., & de Courten, B. V. (2019) · Nutrients · doi:10.3390/nu11061196 · Cited by 107
Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese
Kwan, P., Baum, L., Wong, V. C. N., Ng, P. W., Lui, C. H. T., Sin, N. C., Hui, A. C.-F., Yu, E., & Wong, K. S. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.04.013 · Cited by 106
Self-citationAntiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
Louis, E. K. S., Rosenfeld, W. E., & Bramley, T. J. (2009) · Current Neuropharmacology · doi:10.2174/157015909788848866 · Cited by 106
Seizure outcome and its predictors after temporal lobe epilepsy surgery in patients with normal MRI
Fong, J. S., Jehi, L. E., Najm, I., Prayson, R. A., Busch, R. M., & Bingaman, W. E. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03091.x · Cited by 105
Neurostimulation in the treatment of epilepsy
Bergey, G. K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.04.004 · Cited by 105
Chan, A. Y., Rolston, J. D., Lee, B., Vadera, S., & Englot, D. J. (2018) · Journal of neurosurgery · doi:10.3171/2017.12.jns172331 · Cited by 105
Mitochondrial calcium cycling in neuronal function and neurodegeneration
Walters, G. C., & Usachev, Y. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1094356 · Cited by 105
“Unfortunately, 30% of patients have epilepsy that is poorly controlled by current pharmaceuticals, a condition referred to as refractory epilepsy (Kwan and Brodie, 2000).”
BackgroundPanebianco, M., Sridharan, K., & Ramaratnam, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001524.pub3 · Cited by 105
Metadata
- Authors
- Kwan, P., & Brodie, M. J.
- Affiliations
- Western Infirmary (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-02-03
- Volume
- 342
- Issue
- 5
- Pages
- 314-319
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1974809694
- Cited by
- 5,204
- References
- 39
- Citations by year
- 2026: 225 · 2025: 241 · 2024: 259 · 2023: 275 · 2022: 269 · 2021: 328 · 2020: 348 · 2019: 253 · 2018: 270 · 2017: 228 · 2016: 249 · 2015: 230 · 2014: 205 · 2013: 233 · 2012: 248
- FWCI
- 55.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- CRC Press eBooks (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- drug-resistant epilepsy, antiepileptic drugs, seizure control, newly diagnosed epilepsy, idiopathic epilepsy, symptomatic epilepsy, cryptogenic epilepsy, seizure frequency, predictors of treatment failure, adverse drug reactions, polypharmacy
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anticonvulsants, Child, Epilepsy, Female, Humans, Male, Middle Aged, Prospective Studies, Remission Induction, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review